Minocycline Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Minocycline Hydrochloride
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minocycline Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 16 USDMF, 6 CEP/COS, 3 JDMF, 2 KDMF, 12 NDC API, 12 Listed Suppliers, $ API Reference Price

25 API Suppliers
16 USDMF
6 CEP/COS
3 JDMF
2 KDMF
12 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

55 Drugs in Development

55 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

178 FDF Dossiers, 138 FDA Orange Book, 3 Europe, 7 Canada, 4 Australia, 6 South Africa, 20 Listed Dossiers

178 FDF Dossiers
138 FDA Orange Book
3 Europe
7 Canada
4 Australia
6 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 50MG BASE
CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 8 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 29 Controlled & Modified Release, 28 Thickeners and Stabilizers, 27 Lubricants & Glidants, 24 Solubilizers, 24 Direct Compression, 23 Granulation, 21 Disintegrants & Superdisintegrants, 20 Film Formers & Plasticizers, 18 Topical, 13 Co-Processed Excipients, 13 Parenteral, 10 Taste Masking, 9 Empty Capsules, 8 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers

73 Fillers, Diluents & Binders
52 Coating Systems & Additives
29 Controlled & Modified Release
28 Thickeners and Stabilizers
27 Lubricants & Glidants
24 Solubilizers
24 Direct Compression
23 Granulation
21 Disintegrants & Superdisintegrants
20 Film Formers & Plasticizers
18 Topical
13 Co-Processed Excipients
13 Parenteral
10 Taste Masking
9 Empty Capsules
8 Emulsifying Agents
8 Chewable & Orodispersible Aids
6 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
4 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 69 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
69 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 21 Finished Drug Prices, 4 Annual Reports

6 US Medicaid Prescriptions
21 Finished Drug Prices
4 Annual Reports

MARKET PLACE

33 APIs, 2 FDF Dossiers

33 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

87 US Patents, 1 US Exclusivities, 3 Health Canada Patents

87 US Patents
1 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 2 Others

2 EDQM
1 USP
2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,137 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 1Johnson & Johnson Inc.

02 2Blank

filter Patent Reset all filters

3 All

01 11330533

02 12006105

03 12006106

filter Product Reset all filters

3 All

01 1Minocycline Hydrochloride

02 2Blank

filter Dosage Reset all filters

3 All

01 1Extended Release Powder

02 2Blank

filter Exp Date Reset all filters

3 All

01 22009-12-20

02 12011-07-05

Suanfarma Minocycline Hydrochloride

Product Main Page

01

Johnson & Johnson Inc.

Minocycline Hydrochloride

The Generic Rx Session

Not Confirmed

Johnson & Johnson Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-05

Date Granted : 1994-07-05

Minocycline Hydrochloride

Brand Name : ARESTIN MICROSPHERES

Patent Number : 1330533

Filing Date : 1988-05-24

Strength per Unit : 1mg/4mg Cartridge

Dosage Form : Extended Release Powder

Human Or VET : Human

Route of Administration : Sub Gingival

Patent Expiration Date : 2011-07-05

Date Granted : 1994-07-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Minocycline Hydrochloride

The Generic Rx Session

Not Confirmed

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2009-12-20

Date Granted :

Minocycline Hydrochloride

Brand Name :

Patent Number : 2006105

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-12-20

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Minocycline Hydrochloride

The Generic Rx Session

Not Confirmed

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2009-12-20

Date Granted :

Minocycline Hydrochloride

Brand Name :

Patent Number : 2006106

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-12-20

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!